ArticleInternational journal of legal medicine1997
Evaluation of new primers for CSF1PO.
Article in International journal of legal medicine, 1997. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- False homozygosities at CSF1PO loci revealed by discrepancies between two kits in Chinese population.International journal of legal medicine · 2010Article
- Evaluation of miniY-STR multiplex PCR systems for extended 16 Y-STR loci.International journal of legal medicine · 2008Article
- Y-STR analysis of degraded DNA using reduced-size amplicons.International journal of legal medicine · 2007Article
- A new "miniSTR-multiplex" displaying reduced amplicon lengths for the analysis of degraded DNA.International journal of legal medicine · 2006Article
- New sensitive amplification primers for the STR locus D2S1338 for degraded casework DNA.International journal of legal medicine · 2003Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
We describe new primers for the detection of the STR polymorphism at the CSF1PO locus. These primers have been designed to produce shorter amplicons (150-182 bp) than the primers in standard use (295-327 bp). The reliability of the new primers for CSF1PO typing has been demonstrated by testing on known samples and by sequence analysis. These primers are superior to the original primers with regard to electrophoretic resolution and utility for typing of severely degraded DNA.
Indexed as
Identifiers
9081240What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.